糖尿病合并慢性肾衰竭患者的高血糖管理
Management of hyperglycemia in patients with diabetes mellitus and chronic renal failure.
作者信息
Sampanis Ch
机构信息
Diabetes Center, 2nd Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece.
出版信息
Hippokratia. 2008 Jan;12(1):22-7.
Abstract
Diabetes mellitus is recognized as a leading cause of chronic kidney disease and end-stage renal failure. Chronic renal failure is associated with insulin resistance and, in advanced renal failure, decreased insulin degradation. Both of these abnormalities are partially reversed with the institution of dialysis. Except for diet with protein restriction, patients with diabetes should be preferably treated with insulin. The management of the patients with hyperglycemia and chronic renal failure calls for close collaboration between the diabetologist and the nephrologists. This collaboration is very important so that the patient will not be confused and will not lose confidence to the doctors. Furthermore good glycemic control in these patients seems to reduce microvascular and macrovascular complications.
摘要
糖尿病被认为是慢性肾脏病和终末期肾衰竭的主要原因。慢性肾衰竭与胰岛素抵抗有关，在晚期肾衰竭中，胰岛素降解减少。透析治疗可部分逆转这两种异常情况。除了限制蛋白质饮食外，糖尿病患者最好使用胰岛素治疗。糖尿病合并慢性肾衰竭患者的管理需要糖尿病专家和肾病专家密切合作。这种合作非常重要，这样患者就不会感到困惑，也不会对医生失去信心。此外，对这些患者进行良好的血糖控制似乎可以减少微血管和大血管并发症。
相似文献
1
Management of hyperglycemia in patients with diabetes mellitus and chronic renal failure.糖尿病合并慢性肾衰竭患者的高血糖管理
Hippokratia. 2008 Jan;12(1):22-7.
2
Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease.使用连续血糖监测评估和管理糖尿病及慢性肾脏病患者。
Front Endocrinol (Lausanne). 2022 Apr 22;13:869899. doi: 10.3389/fendo.2022.869899. eCollection 2022.
3
Management of hyperglycemia in patients with chronic kidney disease.慢性肾脏病患者的高血糖管理。
J Nephrol. 2013 Jul-Aug;26(4):629-35. doi: 10.5301/jn.5000248. Epub 2013 Jun 20.
4
Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.2型糖尿病患者严格血糖控制相关问题。
Ann Pharmacother. 1998 Sep;32(9):896-905. doi: 10.1345/aph.17375.
5
Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia.强化血糖控制在糖尿病管理和住院高血糖中的应用。
Am J Health Syst Pharm. 2010 May 15;67(10):798-805. doi: 10.2146/ajhp090211.
6
Diabetes in the elderly population.老年人群中的糖尿病
Adv Ren Replace Ther. 2000 Jan;7(1):32-51. doi: 10.1016/s1073-4449(00)70004-5.
7
Glycemic Monitoring and Management in Advanced Chronic Kidney Disease.血糖监测与管理在慢性肾脏病晚期中的应用。
Endocr Rev. 2020 Oct 1;41(5):756-74. doi: 10.1210/endrev/bnaa017.
8
Managing diabetes in dialysis patients.透析患者的糖尿病管理。
Postgrad Med J. 2012 Mar;88(1037):160-6. doi: 10.1136/postgradmedj-2011-130354. Epub 2012 Jan 25.
9
Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.糖尿病分类与诊断标准委员会报告。
Diabetes Res Clin Pract. 2002 Jan;55(1):65-85. doi: 10.1016/s0168-8227(01)00365-5.
10
Early Post-Renal Transplant Hyperglycemia.肾移植后早期高血糖症
J Clin Endocrinol Metab. 2022 Jan 18;107(2):549-562. doi: 10.1210/clinem/dgab697.
引用本文的文献
1
The correlation between admission hyperglycemia and 30-day readmission after hip fracture surgery in geriatric patients: a propensity score-matched study.老年髋部骨折术后患者入院高血糖与 30 天再入院的相关性：一项倾向评分匹配研究。
Front Endocrinol (Lausanne). 2024 Feb 21;15:1340435. doi: 10.3389/fendo.2024.1340435. eCollection 2024.
2
Protective effect of eriodictyol against hyperglycemia-induced diabetic nephropathy in rats entails antioxidant and anti-inflammatory effects mediated by activating Nrf2.圣草酚对大鼠高血糖诱导的糖尿病肾病的保护作用需要通过激活Nrf2介导抗氧化和抗炎作用来实现。
Saudi Pharm J. 2023 Nov;31(11):101817. doi: 10.1016/j.jsps.2023.101817. Epub 2023 Oct 5.
3
Use of Glucose-Lowering Agents in Diabetes and CKD.降糖药物在糖尿病和慢性肾脏病中的应用
Kidney Int Rep. 2022 Sep 29;7(12):2589-2607. doi: 10.1016/j.ekir.2022.09.018. eCollection 2022 Dec.
4
Renoprotective Roles of Curcumin.姜黄素的肾保护作用。
Adv Exp Med Biol. 2021;1328:531-544. doi: 10.1007/978-3-030-73234-9_38.
5
Dialysis-associated hyperglycemia: manifestations and treatment.透析相关性高血糖症：临床表现与治疗。
Int Urol Nephrol. 2020 Mar;52(3):505-517. doi: 10.1007/s11255-019-02373-1. Epub 2020 Jan 18.
6
Management of Diabetes Mellitus in Normal Renal Function, Renal Dysfunction and Renal Transplant Recipients, Focusing on Glucagon-Like Peptide-1 Agonist: A Review Based upon Current Evidence.正常肾功能、肾功能障碍和肾移植受者的糖尿病管理，重点关注胰高血糖素样肽-1 激动剂：基于现有证据的综述。
Int J Mol Sci. 2019 Jun 28;20(13):3152. doi: 10.3390/ijms20133152.
7
Adult Nesidioblastosis in Chronic Kidney Disease.慢性肾脏病中的成人胰岛细胞增殖症
Case Rep Endocrinol. 2019 Feb 14;2019:7640384. doi: 10.1155/2019/7640384. eCollection 2019.
8
In Silico Testing of an Artificial-Intelligence-Based Artificial Pancreas Designed for Use in the Intensive Care Unit Setting.用于重症监护病房的基于人工智能的人工胰腺的计算机模拟测试。
J Diabetes Sci Technol. 2016 Nov 1;10(6):1360-1371. doi: 10.1177/1932296816653967. Print 2016 Nov.
9
Management of anemia in patients with diabetic kidney disease: A consensus statement.糖尿病肾病患者贫血的管理：一项共识声明。
Indian J Endocrinol Metab. 2016 Mar-Apr;20(2):268-81. doi: 10.4103/2230-8210.176348.
10
Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control.慢性肾脏病患者的糖尿病管理：治疗前景与血糖控制
Clinics (Sao Paulo). 2016 Jan;71(1):47-53. doi: 10.6061/clinics/2016(01)08.
本文引用的文献
1
Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction.加拿大糖尿病协会2013年加拿大糖尿病预防与管理临床实践指南。引言。
Can J Diabetes. 2013 Apr;37 Suppl 1:S1-3. doi: 10.1016/j.jcjd.2013.01.009. Epub 2013 Mar 26.
2
Effect of pioglitazone on heart function and N-terminal pro-brain natriuretic peptide levels of patients with type 2 diabetes.吡格列酮对2型糖尿病患者心脏功能及N末端脑钠肽前体水平的影响
Acta Diabetol. 2008 Mar;45(1):23-30. doi: 10.1007/s00592-007-0014-7. Epub 2007 Sep 4.
3
Standards of medical care in diabetes--2007.《2007年糖尿病医疗护理标准》
Diabetes Care. 2007 Jan;30 Suppl 1:S4-S41. doi: 10.2337/dc07-S004.
4
K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.《K/DOQI 透析患者心血管疾病临床实践指南》
Am J Kidney Dis. 2005 Apr;45(4 Suppl 3):S1-153.
5
Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.胰岛素和口服降糖药物在糖尿病合并晚期肾病患者中的应用。
Semin Dial. 2004 Sep-Oct;17(5):365-70. doi: 10.1111/j.0894-0959.2004.17346.x.
6
Tests of glycemia in diabetes.糖尿病患者的血糖检测
Diabetes Care. 2004 Jan;27 Suppl 1:S91-3. doi: 10.2337/diacare.27.2007.s91.
7
Effect of Kimmelstiel-Wilson syndrome on insulin requirements in diabetes.结节性糖尿病性肾小球硬化症对糖尿病患者胰岛素需求量的影响。
N Engl J Med. 1955 Mar 10;252(10):388-91. doi: 10.1056/NEJM195503102521004.
8
Pharmacokinetics of nateglinide and its metabolites in subjects with type 2 diabetes mellitus and renal failure.
Clin Nephrol. 2003 Aug;60(2):90-5. doi: 10.5414/cnp60090.
9
Decreased insulin requirement in relation to GFR in nephropathic Type 1 and insulin-treated Type 2 diabetic patients.
Diabet Med. 2003 Aug;20(8):642-5. doi: 10.1046/j.1464-5491.2003.01025.x.
10
Assessing glycemic control in patients with diabetes and end-stage renal failure.评估糖尿病合并终末期肾衰竭患者的血糖控制情况。
Am J Kidney Dis. 2003 Mar;41(3):523-31. doi: 10.1053/ajkd.2003.50114.
Zotero 插件